Article | August 19, 2022

Formulation Considerations For Pediatric Populations: Finding The Right Dosage Form For Better Adherence


Medication adherence is influenced by several factors – the method of treatment, healthcare accessibility, a patient’s socioeconomic status, and the palatability and swallowability of a drug all play a role in influencing a patient’s adherence. For pediatric populations, adherence can be complicated by other considerations, such as a child’s ability or willingness to accommodate any bitterness or formulation texture issues. Liquid and chewable formulations are common for pediatric medications. While many active pharmaceutical ingredients (APIs) can be adequately masked in such formulations, numerous bitter APIs present formulation challenges that can benefit from novel taste-masking approaches.

By partnering with a contract development and manufacturing organization (CDMO) with experience in pediatric formulation, pharmaceutical companies can increase acceptability of their drugs among pediatric patients. Pediatric patient idiosyncrasies and an increased regulatory focus on adherence impacts a pharmaceutical landscape that is also shifting toward more patient-centered, at-home care. With regulatory bodies emphasizing the importance of co-developing pediatric formulations from the beginning of a drug’s development, coordinated, comprehensive scale-up and manufacturing is integral to a treatment’s ultimate commercial and therapeutic success.

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Pharmaceutical Online? Subscribe today.

Subscribe to Pharmaceutical Online X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.


Subscribe to Pharmaceutical Online